642 In a multicenter, randomized, double-blind, placebo-controlled phase-3 clinical trial conducted in China, acetyllevocarnitine hydrochloride treatment for 24 weeks significantly improved symptoms and somatosensory symptoms in patients with DPN, with a treatment effect of 65% higher than placebo
Tirzepatide should only be injected into the three approved areas: the abdomen, thigh, or back of the upper arm
A typical loading approach might use 0.75mg to 1mg daily for the first 3 to 5 days, then reduce to 0.5mg for the remainder of the protocol
Drugs containing these antibodies are called monoclonal antibodies, and they are used to treat autoimmune conditions (e.g., rheumatoid arthritis, psoriasis, lupus, inflammatory bowel disease), as well as several other diseases like cancer, heart disease, and COVID-19 (per MedicineNet)